Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

European Innovation Council · Running

AOscopy Adaptive Optics-enhanced multiphoton microscopy

Coordinator
Imagine Optic SA, France
Runs
1 June 2025 to 31 May 2028
Status
Running
EU funding
€2.4m
Total cost
—
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
101214841

What the project is doing

In the project's own words, from its summary on CORDIS.

AOscopy aims to establish, quantify and validate the value offer of next-generation multiphoton microscopy using Adaptive Optics (AO), for several applicative use cases in biology, as a key milestone for future exploitation. When targeting deep imaging of biological tissue with subcellular 3D resolution, multiphoton microscopy is the technique of choice, thanks to a unique capability to provide fluorescence images with sub-micron 3D resolution even in scattering media.

Due to these features, multiphoton microscopy is widely used in application fields such as e.g. neuroscience, immunology, oncology, dermatology or developmental biology, as a key tool to enable better understanding of both morphological and functional characteristics of biological systems, with a view on improved diagnosis and therapy of multiple diseases. However, it is most of the time severely limited by the intrinsic optical inhomogeneity of biological media, which is responsible for a limitation of imaging depth and sensitivity.

While AO has proven its capability to overcome this limitation, no integrated, robust AO-enhanced multiphoton microscope is currently available, as an answer to the need from biologists to routinely and easily image deeper, with enhanced contrast, and reduced phototoxicity. AOscopy will: 1. Develop a prototype of an AO-2-photon microscope, based on our recent innovations, enabling to achieve strong signal enhancement (typ. x5), at large depths in biological media (typ. ≥700µm in the mouse brain), while reducing phototoxicity; 2.

Perform market/applicative tests, through the use of the prototype by representative end-users, in order to precise, quantify and validate its value offer in intended environement, for several application fields; 3.Create, structure and develop a start-up company 100% dedicated to AO-based microscopy, in order to accelerate its exploitation and adoption.

Topics

Who is involved

OrganisationCityCountryRole
Imagine Optic SAOrsayFranceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI